Salmonella occupies a vacuolar compartment inside cells of its host. Recent studies have shown that the fate of this vacuole is different in various cell types, and that the outcome of colonization is determined by both the infecting bacterium and defense mechanisms of the host cell. 
Trafficking of the Salmonella vacuole
The estimated 2200 different serovars of Salmonella can infect most animals, with the outcome of infection determined by the genetic complement and fitness of both the infecting Salmonella serovar and its host. Salmonella enterica serovar Typhimurium (S. Typhimurium) is a leading cause of gastroenteritis (food poisoning) in humans and causes a systemic disease resembling typhoid fever in genetically susceptible mice, making it a powerful model for the study of both diseases. Infections are initiated by consumption of contaminated food or water, after which the bacteria breach the epithelial barrier of the small intestine and enter the bloodstream to colonize the liver, spleen and other tissues. During this conquest of the host, S. Typhimurium occupies an intracellular niche and is protected from cell-impermeant antibiotics [2] . How this pathogen can perform such a feat during its interaction with many diverse cell types of the host is an important and hotly debated question.
As early stages of infection involve interaction with the intestinal epithelium, many investigators have focused on interactions of S. Typhimurium with epithelial cell lines in vitro. These studies have revealed the mechanisms by which this pathogen can invade these non-phagocytic cells in a manner dependent on rearrangements of the actin cytoskeleton [3] . Following invasion, the bacteria can survive and replicate within a membrane-bound compartment, the Salmonella-containing vacuole (SCV). While it was previously thought that fusion of the SCV with late endocytic compartments was blocked, a recent study has demonstrated that fusion is merely delayed [4] . Indeed, several hours after infection, the SCV fuses extensively with late endosomes, causing it to elongate into tubules known as Salmonella-induced filaments (Sifs). This dramatic phenotype is dependent on SifA, a virulence protein of S. Typhimurium that is translocated from the bacteria into host cells by a needle-like protein delivery apparatus called the SPI-2 type III secretion system. Sifs are unique to Salmonella infection of epithelial cells in vitro, though their role during infection in vivo remains unknown.
During systemic phases of disease in mice, S. Typhimurium is found in macrophages in both the liver [5] and spleen [6] . Maintenance of the SCV is accomplished both in vitro [7] and in vivo [6] by the actions of SifA, which plays a major role in virulence as loss of the SCV results in death of the bacteria in the macrophage cytosol. While SifA keeps S. Typhimurium within a vacuolar niche, other factors alter the fate of this compartment. For example, the SPI-2 type III secretion system has recently been shown to block assembly and delivery of the NADPH oxidase, a multiprotein superoxide generating complex that plays a major role in innate host defense, to the SCV [8, 9] . By preventing delivery of the NADPH oxidase, intracellular S. Typhimurium is able to minimize its exposure to toxic free radicals of oxygen. S. Typhimurium has also been shown to block fusion of the SCV with lysosomes in macrophages [10, 11] , an observation that now provides a contrast to SCV trafficking in epithelial cells [4] . These studies reveal the complexity with which S. Typhimurium can alter SCV integrity and trafficking within a given host cell, though the mechanisms by which this occurs remain undetermined.
Dendritic cells are antigen-presenting cells located in central lymphoid organs and Peyer's patches of the intestine. S. Typhimurium can occupy this cell type in the mouse model of infection [12] , though in vitro studies suggest that replication in this cell type is limited [13, 14] . Interestingly, survival in dendritic cells does not require virulence factors that are essential for macrophage colonization, suggesting that different effectors are involved [14] . As in other cell types, the SCV consists of a single limiting membrane and is distinct from the multilamellar compartments containing major histocompatability complex (MHC) class II Bacterial determinants of intracellular replication S. Typhimurium does not replicate in fibroblasts [19] , suggesting that this cell type is capable of restricting intracellular replication by this pathogen. Exciting new results have now suggested that it may, in fact, be the bacteria that dictate when and in which cell types replication will occur. Cano et al. [20] have reported the isolation of a variety of S. Typhimurium mutants that exhibit increased proliferation within NRK cells, a rat kidney fibroblast cell line. Surprisingly, these strains harbor mutations in many of the key S. Typhimurium virulence regulators required for systemic disease in animal models and for normal levels of replication in mouse macrophages. This suggests that S. Typhimurium uses these regulatory elements to sense which cell type it occupies, adjusting its own replication accordingly. The mechanisms by which S. Typhimurium controls its own replication in fibroblasts remain unknown, and it remains to be determined if intracellular trafficking of the SCV plays a role. Fibroblasts may provide S. Typhimurium with protection from the host immune system, while creating a reservoir of intracellular bacteria with which to mediate persistent infection. This represents the first example of an intracellular bacterial pathogen capable of attenuating its own replication within a eukaryotic cell.
Biological significance
Extensive study of S. Typhimurium has revealed how a single pathogen can occupy a unique intracellular compartment inside different cell types of its host. This reflects a complex adaptation to the infection of multicellular animals, and a complete virulence strategy from entry to exit. These findings force us to think differently about intracellular pathogenesis, and the question of whether other intracellular pathogens 
